{"date":"2025-04-22","count":14,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6645-2025-04-22-1841-1u9lkxf","company_id":"6645","company":"金萬林-創","market":"上市","industry":"生技醫療","date":"2025-04-22","time":"18:41:13","subject":"公告本公司董事會決議買回庫藏股(更正買回股份總金額上限及預定買回股份總數等事項)","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：金萬林-創（6645），2025-04-22 18:41，「公告本公司董事會決議買回庫藏股(更正買回股份總金額上限及預定買回股份總數等事項)」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6976-2025-04-22-1706-1eah7sb","company_id":"6976","company":"育世博-KY","market":"興櫃","industry":"生技醫療","date":"2025-04-22","time":"17:06:08","subject":"公告本公司受邀參加凱基證券舉辦之法說會","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：育世博-KY（6976），2025-04-22 17:06，「公告本公司受邀參加凱基證券舉辦之法說會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6936-2025-04-22-1654-1fry2sp","company_id":"6936","company":"永鴻生技","market":"上市","industry":"生技醫療","date":"2025-04-22","time":"16:54:09","subject":"公告本公司股票初次上市前現金增資員工認購股款催繳事宜","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：永鴻生技（6936），2025-04-22 16:54，「公告本公司股票初次上市前現金增資員工認購股款催繳事宜」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4170-2025-04-22-1547-100x4ao","company_id":"4170","company":"鑫品生醫","market":"興櫃","industry":"生技醫療","date":"2025-04-22","time":"15:47:30","subject":"本公司董事會決議不分配股利","clause":"第31款","fact_date":"2025-04-22","cite_as":"公開資訊觀測站重大訊息：鑫品生醫（4170），2025-04-22 15:47，「本公司董事會決議不分配股利」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4170-2025-04-22-1546-1pe5i2t","company_id":"4170","company":"鑫品生醫","market":"興櫃","industry":"生技醫療","date":"2025-04-22","time":"15:46:58","subject":"公告本公司董事會決議通過113年度合併財務報告","clause":"第43款","fact_date":"2025-04-22","cite_as":"公開資訊觀測站重大訊息：鑫品生醫（4170），2025-04-22 15:46，「公告本公司董事會決議通過113年度合併財務報告」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6945-2025-04-22-1534-zodqmy","company_id":"6945","company":"圓祥生技","market":"上櫃","industry":"生技醫療","date":"2025-04-22","time":"15:34:40","subject":"代子公司APBIO PTY LTD公告研發中雙特異性抗體抗癌新藥AP402於澳洲治療HER2陽性實體腫瘤第一期臨床試驗完成第一例受試者收案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：圓祥生技（6945），2025-04-22 15:34，「代子公司APBIO PTY LTD公告研發中雙特異性抗體抗癌新藥AP402於澳洲治療HER2陽性實體腫瘤第一期臨床試驗完」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1707-2025-04-22-1532-1r8rub1","company_id":"1707","company":"葡萄王","market":"上市","industry":"生技醫療","date":"2025-04-22","time":"15:32:21","subject":"代本公司重要子公司葡眾企業股份有限公司公告股東常會決議通過解除董事競業禁止之限制","clause":"第21款","fact_date":"2025-04-22","cite_as":"公開資訊觀測站重大訊息：葡萄王（1707），2025-04-22 15:32，「代本公司重要子公司葡眾企業股份有限公司公告股東常會決議通過解除董事競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1707-2025-04-22-1531-1t7nzvi","company_id":"1707","company":"葡萄王","market":"上市","industry":"生技醫療","date":"2025-04-22","time":"15:31:41","subject":"代本公司重要子公司葡眾企業股份有限公司公告114年除息基準日","clause":"第14款","fact_date":"2025-04-22","cite_as":"公開資訊觀測站重大訊息：葡萄王（1707），2025-04-22 15:31，「代本公司重要子公司葡眾企業股份有限公司公告114年除息基準日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-1707-2025-04-22-1530-m6la7l","company_id":"1707","company":"葡萄王","market":"上市","industry":"生技醫療","date":"2025-04-22","time":"15:30:49","subject":"代本公司重要子公司葡眾企業股份有限公司公告114年股東常會重要決議事項","clause":"第18款","fact_date":"2025-04-22","cite_as":"公開資訊觀測站重大訊息：葡萄王（1707），2025-04-22 15:30，「代本公司重要子公司葡眾企業股份有限公司公告114年股東常會重要決議事項」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-04-22-1443-9oiiba","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-04-22","time":"14:43:01","subject":"代重要子公司鼎晉生技股份有限公司公告設置薪酬委員會及第一屆委員名單","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-04-22 14:43，「代重要子公司鼎晉生技股份有限公司公告設置薪酬委員會及第一屆委員名單」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-04-22-1442-17dc11r","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-04-22","time":"14:42:21","subject":"代重要子公司鼎晉生技股份有限公司公告新任發言人及代理發言人","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-04-22 14:42，「代重要子公司鼎晉生技股份有限公司公告新任發言人及代理發言人」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4174-2025-04-22-1441-r9237h","company_id":"4174","company":"浩鼎","market":"上櫃","industry":"生技醫療","date":"2025-04-22","time":"14:41:36","subject":"代重要子公司鼎晉生技股份有限公司公告新任財務及會計主管","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：浩鼎（4174），2025-04-22 14:41，「代重要子公司鼎晉生技股份有限公司公告新任財務及會計主管」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6492-2025-04-22-1400-q203yi","company_id":"6492","company":"生華科","market":"上櫃","industry":"生技醫療","date":"2025-04-22","time":"14:00:19","subject":"公告本公司重要營運主管異動案","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：生華科（6492），2025-04-22 14:00，「公告本公司重要營運主管異動案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4188-2025-04-22-0919-19euwv1","company_id":"4188","company":"安克","market":"上櫃","industry":"生技醫療","date":"2025-04-22","time":"09:19:05","subject":"公告本公司114年第一季財務報告董事會召開日期為114年4月29日","clause":"","fact_date":"","cite_as":"公開資訊觀測站重大訊息：安克（4188），2025-04-22 09:19，「公告本公司114年第一季財務報告董事會召開日期為114年4月29日」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}